Fulcrum Therapeutics, Inc. FULC Q1 2025 earnings
Reported May 1, 2025 · Before market open
EPS-$0.28Beat by $0.01
EPS estimate-$0.29
Next report
Aug 4, 2026 (In 6 days)EPS estimate-$0.21
Versus estimates
Diluted EPS
Ask the moment Fulcrum Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Fulcrum Therapeutics, Inc. report Q1 2025 earnings?
- Fulcrum Therapeutics, Inc. (FULC) reported Q1 2025 earnings on May 1, 2025 before market open.
- What were Fulcrum Therapeutics, Inc.'s Q1 2025 revenue and EPS?
- Fulcrum Therapeutics, Inc. reported eps of $-0.28 for Q1 2025.
- Did Fulcrum Therapeutics, Inc. beat estimates in Q1 2025?
- EPS beat the consensus estimate of $-0.29 by $0.01.
- How did Fulcrum Therapeutics, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 34.9% from $-0.43.
- Where can I find Fulcrum Therapeutics, Inc.'s Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-061442) directly on SEC EDGAR. The filing index links above go to sec.gov.